Enovis (C520) Q2 2026 Earnings Report

The call was broadly positive. Enovis delivered 5% organic growth, strong U.S. Recon and new-product momentum, improved margins, higher adjusted EPS, a significant improvement in free cash flow, and progress on deleveraging while reaffirming 2026 guidance. The principal challenges were inflation, tariffs, Middle East-related disruption, softer Western European markets, and a seasonally more difficult third quarter, but management expressed confidence in commercial execution and second-half acceleration.

Enovis is reaffirming its 2026 guidance, including free cash flow conversion of greater than 25% in 2026; the $8 million benefit from the partial tariff refund is expected to be offset by $10 million of full year impact from the increased inflationary environment. The company expects the third quarter to have a heavier impact by seasonality than in prior years, with a more seasonally soft Q3 than what we have seen in the past, zero impact year-over-year from selling days, and greater pressure from Western Europe and the conflicts in the Middle East; it expects sales acceleration across both segments in the fourth quarter, with one day in Q4 in terms of selling day impact, as new products scale and launch against improving market volumes. New products are expected to start contributing more as we get into the later part of the year, and the company expects continued adoption in shoulders as we move through the second half of 2026. For 2027, the margin algorithm and cash algorithm are still intact, while the company’s goal is to get leverage down below three here this year.